|
|
||||||||
|
FIGURE 3. (A) White blood cell counts before therapy and at week 6. (B) Platelet counts before therapy and at week 6. Dashed lines represent sessions 6a and 6b. (C) Bilirubin levels before therapy and at weeks 2 and 6 after therapy. (D) AST levels before therapy and at weeks 2 and 6 after therapy.
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |